Opinion: CHIPS Act Escalates Long-Standing U.S.-China Tech Rivalry
By Richard L. Thurston
EETimes (August 10, 2022)
As U.S. House Speaker Nancy Pelosi flew to Taipei last week, President Joe Biden signed the CHIPS and Science Act in an effort to boost U.S. semiconductor production. But will it increase U.S. semiconductor competitiveness, or will it set back the U.S. industry in its ongoing technology rivalry with China? I fear the latter.
While providing billions of dollars in subsidies to the semiconductor industry in the form of fab construction grants, investment tax credits, and science and R&D incentives, for example, the CHIPS Act more dangerously imposes significant restrictions on chipmakers that would accept such U.S. incentives and that would also invest in their China operations during a 10–year period. Why will this legislation be detrimental to the U.S. semiconductor industry?
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- CEA-Leti Announces FAMES Pilot Line In Nature Reviews Electrical Engineering
- U.S.-China Tech War Likely to Escalate, Analysts Say
- CEA-Leti Announces Launch of FAMES Pilot Line As Part of EU Chips Act Initiative
- Crucial role for imec in EU Chips Act
- U.S. Subsidy for TSMC Has AI Chips, Tech Leadership in Sight
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design